Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 14/09/2026In honor of #PeerReviewWeek we would like to thank our peer reviewers for their important and insightful contributions to CMI. We deeply value the time, effort and expertise that goes into writing each peer-review. 044
Reposted by Amy LeggCMI Communications @cmicomms.bsky.social · 23/08/2026🎙️ Just published Communicable E61: We will make you love PK/PD, part 3 Hosted by Amy Legg, Rekha Pai & Angela Huttner with invited guests Amanda Gwee (@amandagwee.bsky.social) & Sebastian Wicha 🌟 Listen on #Communicable: share.transistor.fm/s/c4af55ab #IDSky #clinmicroshare.transistor.fmCommunicable | Communicable E61: We will make you love PK/PD, part 3 064
Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 06/07/2026🌟 The 2025 JCR Impact Factor for CMI has risen to 8.7! We thank our editors, reviewers, authors and readers for their dedication and extraordinary work. Read about how CMI did in 2025 here: clinicalmicrobiologyandinfection.org/article/S119... #IDSky #MicroSky #JIF #JCR2025 064
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 28/06/2026🦠 ID Folk — antibiotic allergy is no longer a niche topic, it's part of AMS practice! Join us at #DHS2026 (Melbourne, 23–25 Oct 26) for sessions on: 🔹 Direct oral challenge 🔹 Clinical trials 🔹 SCAR 🔹 Drug anaphylaxis 🔹 AMS 📢 Abstract submissions close 31/7/26 🔗 dhs2026.org/abstracts/dhs2026.orgAbstracts - DHS2026Abstracts Important Dates Abstract submission closes: 31 July 2026, 11:59 PM (AEST) Abstract Submission Guidelines Eligibility Abstracts must be submitted by the presenting author or a nominated co-a... 021
Reposted by Amy LeggJosh Davis @gurujosh.bsky.social · 24/06/2026Calling all data scientists! Come and work with the world-leading SNAP trial team at University of Newcastle, HMRI and the Doherty Institute. Please tell all your data nerd friends and colleagues! www.livehire.com/careers/univ...livehire.comSNAP Trial Data Co-ordinator - University of NewcastleFullTimeFixedTerm • New Lambton Heights NSW 2305, Australia • Contribute to a high-impact trial by ensuring data is accurate, reliable, and ready to inform critical research findings 052
Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 23/06/2026Strengthen your clinical research skills at this onsite course. Explore study design, bias reduction, scientific writing, and the latest developments in clinical trial methodology through practical, project-based learning. Learn more & sign up today! ow.ly/nC9l50Zb6nM 023
Amy Legg @leggwamy.bsky.social · 16/06/2026Recent paper 🚨 @cmijournal.bsky.social ‘this meta-analysis revealed that individuals with TLR polymorphisms have nearly double the risk of developing fungal infections compared to those without mutations…. #dontblamethehost #IDsky Genomics with a roll to play in AST and pathogenicity! 130
Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 12/06/2026July 2026 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-... 033
Reposted by Amy LeggCMI Communications @cmicomms.bsky.social · 12/06/2026📣 If you have questions about fosfomycin, we have answers! Excellent review article by Tiffany Wu, Kalpana Gupta, @erinmccreary.bsky.social, Sarah Turbett & Jacob Lazarus on oral #fosfomycin & how to use it. #IDSky #clinmicro #UTISky #Medsky #Pharmsky www.cmi-comms.org/article/S295...cmi-comms.orgOral fosfomycin tromethamine for UTI: Guidance for cliniciansOral fosfomycin is a guideline-recommended first-line treatment for uncomplicated cystitis. However, fosfomycin has demonstrated lower clinical and/or microbiological cure rates compared with other an... 085
Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 08/06/2026A practical “How to” guide for laboratories, researchers, and AST developers working with EUCAST breakpoints. Read here: www.clinicalmicrobiologyandinfection.org/article/S119... #EUCAST #AST #AMR #Microbiology #IDSky #MicroSky #AntimicrobialResistance 143
Amy Legg @leggwamy.bsky.social · 01/06/2026Incredibly clear set of guidelines for penicillin allergy assessment and management. Currently not recommending multiple day challenges-eagerly awaiting PROSPECTOR2. @idsky.bsky.social 000
Reposted by Amy LeggESCMID @escmid.bsky.social · 01/06/2026The Emerging Infections Subcommittee just published in CMI a rapid assessment of the Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda, covering the current situation and key challenges. ow.ly/rS5s50Z60wO 355
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 24/05/2026Allergists & Immunologists— #DHS2026 is for you. 📍 Melbourne | 📅 23–25 Oct 2026 🔹 Day 1: SCAR, genomics & diagnostics 🔹 Day 2: Antibiotic allergy & stewardship 🔹 Day 3: Drug anaphylaxis & perioperative allergy Limited places — register now! 👉 dhs2026.org #AntibioticAllergy #DrugAllergydhs2026.orgHome - DHS2026Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha... 011
Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 18/05/2026📣 In the June 2026 issue: Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation www.clinicalmicrobiologyandinfection.org/article/S119... 032
Reposted by Amy LeggSteven Tong @steventong.bsky.social · 14/05/2026ESCMID 2026 highlights COBRA Trial – One day is enough Dutch RCT: 1 day of antibiotics after ERCP drainage for cholangitis was non‑inferior to 4–7 days. Bottom line: Antibiotic durations can safely be much shorter once source control is achieved. #IDSky clarityinitiative.org/escmid-2026-...clarityinitiative.orgClarity InitiativeClinical Literature Appraisal and Research education in InfecTious diseases 13117
Reposted by Amy LeggClinical Microbiology and Infection @cmijournal.bsky.social · 13/05/2026📣 New publication: Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment www.clinicalmicrobiologyandinfection.org/article/S119...clinicalmicrobiologyandinfection.orgAndes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessmentThe ongoing cluster of hantavirus infections associated with the cruise ship MV Hondius represents an unusual but instructive event at the intersection of zoonotic spillover, human mobility, confined ... 1126
Amy Legg @leggwamy.bsky.social · 16/05/2026For those needing a one article summary of events-this is it! www.clinicalmicrobiologyandinfection.org/article/S119... #cmi #idposts 012
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 16/05/2026#Pharmacists Join #DHS2026: Challenging Evidence 📍 Melbourne | 📅 23–25 Oct Explore: ✔️ #Antibioticallergy #AMS integration ✔️ Practical skills and case scenario sessions ✔️ #Penicillinallergy Digital health solutions 👉 dhs2026.org #Pharmacy #AntimicrobialStewardship #MedicationSafetydhs2026.orgHome - DHS2026Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha... 022
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 03/05/2026🚨Primary Care🚨 #DHS2026: Challenging Evidence 🧠💊 📍 Melbourne | 📅 23–25 Oct @thedohertyinst.bsky.social ✔️ Primary care–focused sessions ✔️ Practical skills, cases & CPD ✔️ Global experts + real-world insights Bring #drugallergy #antibioticallergy into your practice. 👉 dhs2026.org @racgp.bsky.socialdhs2026.orgHome - DHS2026Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha... 021
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 19/01/2026💊Drug Hypesensitivity Symposium 2026 - #DHS2026 Registrations are now open for our amazing 3-day #drugallergy & #antibioticallergy program in Melbourne 23-25th October 2026. Stellar international🌏speaker lineup. @allergy-eaaci.bsky.social @thedohertyinst.bsky.social ➡️https://dhs2026.org/ 044
Reposted by Amy LeggAngela Huttner @angelahuttner.bsky.social · 21/04/2026Great #UTI session just starting in Hall A2-1. D Neofytos talking now, Barbara Trautner @bwtrautner.bsky.social up next. #ESCMIDGlobal2026 #IDSky #UTISky 182
Reposted by Amy LeggAntibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 20/04/2026▶️💥Tick tock, AMR clock: how should I treat my next ESBL bacteraemia patient? Excellent talk by Prof Tong Carbapenem sparing drug? Do we need it? Data? Does it increase CRE? Bayesian priori Next patient with ESBL : would you give pip tazo or Mero ? #ESCMIDGlobal2026 @steventong.bsky.social 👏 #idsky 1193
Reposted by Amy LeggSociety of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 19/12/2025Ring in the end of the year with our Breakpoints hosts and a review of all things IDWeek 2025! Join Drs. Erin McCreary, Julie Ann Justo, Whitney Buckel, and Ryan Moenster as they cover top abstracts and much more. BCIDP credit is available for this episode! Visit sidp.org/BCIDP for more information 021
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 21/11/2025The largest adult #penicillinallergy study ever undertaken - The iNAAN study @thedohertyinst.bsky.social @unimelb.bsky.social - 52 hospitals, 8 countries and over 5000 patients….Real world proof of the safety and effectiveness of inpatient DOC! Stay tuned #AMS folks 👀Results soon! 0103
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 21/11/2025Is one dose ever enough? The PROSPECTOR 🪓 Trial will answer - A international double blind placebo controlled trial of 1 dose vs 5 day for #penicillinallergy. This week we recruited our 100th patient! 🎉 @thedohertyinst.bsky.social 053
Reposted by Amy LeggCRE Respond @crerespond.bsky.social · 19/09/2025👏CRE RESPOND is thrilled to announce the Sepsis: What is the Latest Data for Optimal Management of Sepsis seminar!👏 🗓️When: Thursday 16 October, 12pm-1pm (AEST) 🗺️Where: UQCCR (or online!) REGISTER HERE: bit.ly/3VBLeSx Don't miss out on the chance to hear from expert clinicians and researchers! 011
Reposted by Amy LeggCRE Respond @crerespond.bsky.social · 19/09/2025The whole team at CRE RESPOND are very proud of our very own Amy Legg on her graduation! Congratulations Amy!! 👏🎉 @leggwamy.bsky.social 111
Amy Legg @leggwamy.bsky.social · 17/09/2025Graduation nation! Huge thanks to the supers @gurujosh.bsky.social @steventong.bsky.social Jane Davies, Jason Roberts. Look after your kidneys guys! 430
Reposted by Amy LeggCRE Respond @crerespond.bsky.social · 17/09/2025🤩Dr Andrew Burke's recent presentation on 'Therapeutic Drug Monitoring in Non-Tuberculous Mycobacteria' was not one to miss... 📢Luckily, even if you weren't able to attend the Respiratory Infections seminar, you won't have to! youtu.be/V2nITG_rxp8?...youtu.be03 Dr Andrew Burke - Therapeutic Drug Monitoring in Non-Tuberculous MycobacteriaYouTube video by cre.respond 011
Reposted by Amy LeggJason Trubiano @trubianojason.bsky.social · 29/08/2025Congratulations Elise Mitri from NACE, Austin Health & The Peter Doherty Institute presenting the iNAAN Trial results - > 5000 pts & 1500 inpatient #penicillinallergy DOC performed. Safe irrespective of stakeholder with significant prescribing gains. Largest inpatient penicillin allergy study 👏🎉 041
Reposted by Amy LeggCRE Respond @crerespond.bsky.social · 18/07/2025On 7 August 2025, we will be hosting our Worldwide Precision Dosing seminar for the fifth year!💉 📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy. To find out more about this event and register: bit.ly/3GtrIUb @leggwamy.bsky.social #UQCCR 011
Amy Legg @leggwamy.bsky.social · 22/05/2025Always happy to celebrate you @minyonavent.bsky.social ❤️ what a packet of legends 010
Reposted by Amy LeggCRE Respond @crerespond.bsky.social · 22/05/2025✨Hello and welcome to the official CRE Respond page!✨ CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊 🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation! #uqccr 031
Reposted by Amy LeggAngela Huttner @angelahuttner.bsky.social · 13/04/2025Congrats to @elisemitri.bsky.social, @trubianojason.bsky.social et al for their great work on safely delabeling patients with #penicillinallergy. Elise presenting their prospective, pharmacist-led program live at #ESCMIDGlobal #IDSky #PharmSky #openacess www.cmi-comms.com/article/S295... 0434
Reposted by Amy LeggJosh Davis @gurujosh.bsky.social · 13/02/2025#SNAPtrial will answer this question in a large RCT (rather than observational). Come to ESCMID global and hear the results! 0235
Reposted by Amy LeggJosh Davis @gurujosh.bsky.social · 09/02/2025Approaching more than all previous SAB trials combined! What next?! 0123
Amy Legg @leggwamy.bsky.social · 05/02/2025Interested in PK modelling? CRE RESPOND is running its Population Pharmacokinetics workshop, from fundamentals to clinical practice. Much more practical program this year! Be quick spaces are limited. Register here: bit.ly/3ElRmJ6bit.lyPopulation pharmacokinetics: from fundamentals to clinical practiceAre you looking to enhance your knowledge of pharmacokinetics (PK) and gain hands-on experience with population pharmacokinetic (popPK) modelling? Whether you are new to the field or looking to deepen... 000
Amy Legg @leggwamy.bsky.social · 23/01/2025Really excited by this article from @idpharmacometrx.bsky.social et al. Protamine as the prototype for megalin blockade to reduce/delay kidney accumulation of vanc (and maybe colistin and aminoglycosides…). But also an excellent VIKI overview, fab pics 💕 journals.asm.org/doi/10.1128/...journals.asm.orgProtamine protects against vancomycin-induced kidney injury | Antimicrobial Agents and ChemotherapyVancomycin is one of the most widely used antibiotics within United States in-patient healthcare systems, accounting for 11.9% of all antibiotic use for inpatient antimicrobials (1,258 out of 10,612) ... 162
Reposted by Amy LeggAntibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 31/12/2024🆕💫Retrospective cohort study #CMI AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC www.clinicalmicrobiologyandinfection.com/article/S119...clinicalmicrobiologyandinfection.comDEFINE_ME 084
Reposted by Amy LeggAntibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 02/01/2025 **Starting 2025 with a key update: The new ATS/CDC/ERS/IDSA guidelines on treating drug-susceptible and drug-resistant tuberculosis (TB) are out! What do you think about these changes? How will they shape clinical practice moving forward?** #idsky #tbsky #EMIMCC 1126
Reposted by Amy LeggAntibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 10/12/2024Pharmacodynamic studies indicate that anaerobic killing is optimized when the plasma AUC) to MIC ratio is ≥70:1; the probability of achieving this target with 1000mg/d of metronidazole is > 99% against B. fragilis that exhibit MICs < 2mg/L #idsky #medsky #EMIMCC 2114
Reposted by Amy LeggAntibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 05/12/2024🆕🔥Retrospective, multicenter, inverse probability-of-treatment weighted cohort study Among hospitalized patients with septic shock, there was no difference between cefepime and piperacillin-tazobactam on the occurrence of severe AKI #idsky #medsky academic.oup.com/cid/advance-... 142
Amy Legg @leggwamy.bsky.social · 05/12/2024Just in case you missed it Dr Emily Heil and Dr Julie Ann Justo with the greatest overview of aminoglycoside dosing for #UQCCR earlier this year! All the recordings here cre-respond.centre.uq.edu.au/event/sessio...cre-respond.centre.uq.edu.auWorldwide Precision Dosing SeminarCRE RESPOND's fourth Annual Worldwide Precision Dosing seminar was held on Tuesday 10 September. Our panel of expert clinicians and clinical educators, from America, Europe and Australia, covered whe... 020
